The sound of Gu Lang Qin, accompanied by the calls of egrets.
Breaking through the haze of the epidemic, the long-awaited “2022 Vision Health Innovation Development International Forum (Vision China 2022)” arrived on schedule at the Xiamen International Conference Center (the main venue of the 9th BRICS Leaders’ Meeting) on July 22nd!
Vision China is an annual event for ophthalmologists, and as a leader in the field of artificial intelligence in Chinese ophthalmology, Big Vision was invited to participate in this grand event, gathering with domestic and foreign experts in ophthalmology and optometry in Xiamen, a land of egrets.
Big Vision (VC-A28) Booth On-site
In recent years, “prevention and control of myopia among children and adolescents” has become a national strategy and is also the most concerned hot topic at Vision China conferences over the years. Big Vision actively responds to the national call and brings its independently developed myopia prevention and warning system for children and adolescents and its Bright Lemon Optometry Management System series products to the VC exhibition, comprehensively demonstrating the product’s overall solution for all scenarios, and exploring new developments and opportunities in the field of optometry with peers.
At this year’s VC exhibition, Big Vision attracted wide attention with its innovative research and development strength and technical accumulation in the field of ophthalmic AI.
The A28 booth welcomed many experts who were interested in experiencing the equipment. One professional ophthalmologist came to the Big Vision booth and asked, “I have been following your promotion of your own software-hardware integrated artificial intelligence (OCT) device. Is this the one? Can you introduce it to me and let me experience it?”
Through the help of the doctor, we were able to switch roles during the on-site experience. With the engineer’s explanation, the doctor quickly became proficient in operating the equipment and conducted a fundus examination for the patient on site. Particularly commendable was the convenience of operating the BV1000, the efficiency of the inspection process, and the AI-assisted diagnosis. Finally, at the exhibition site, the “smart, efficient, and convenient” features of this device were verified. The doctor expressed hope that this artificial intelligence product can be introduced to more hospitals to help improve efficiency and assist with clinical diagnosis and treatment.
Big Vision will continue to explore and fulfill its corporate mission of “early detection of every problematic eye and providing the best treatment plan.” We will use AI to empower ophthalmic diagnosis and treatment, and utilize technologies such as the Internet, IoT, and big data analysis. By paying attention to eye health across all ages and stages of life, we are dedicated to tirelessly striving for universal eye health.
No comments yet.